Update on chronic hepatitis C

Strategies for the diagnosis and treatment of chronic hepatitis C continue to evolve. Liver biopsy is now used selectively rather than routinely, and the combination peginterferon plus ribavirin is the treatment of choice for the majority of patients. Dr. Keeffe acknowledges grant support and memberships on advisory boards and speaker's bureaus of Roche Pharmaceutical and grant support and membership on the speaker' Brueau of Schering Laboratories. Dr. Ahmed acknowledges memberships on advisory boards and speakers' bureaus of Roche Pharmaceutical, Schering Laboratories, and Ortho-Biotech.